- New
-
Topics
- All Categories
- Metaphysics and Epistemology
- Value Theory
- Science, Logic, and Mathematics
- Science, Logic, and Mathematics
- Logic and Philosophy of Logic
- Philosophy of Biology
- Philosophy of Cognitive Science
- Philosophy of Computing and Information
- Philosophy of Mathematics
- Philosophy of Physical Science
- Philosophy of Social Science
- Philosophy of Probability
- General Philosophy of Science
- Philosophy of Science, Misc
- History of Western Philosophy
- Philosophical Traditions
- Philosophy, Misc
- Other Academic Areas
- Journals
- Submit material
- More
Missing the Forest: Further Thoughts on the Ethics of Bystander Risk in Medical Research
Cambridge Quarterly of Healthcare Ethics 16 (4):483 (2007)
Abstract
Developments in the last several years have sparked renewed interest in the ethics of research involving humans. Issues relating to the global extent of research and its guiding principles are of particular importance to researchers, health officials, and individual ethics committees who want a deeper and more encompassing inquire regarding the foundation and evolution of human research. This department of CQ launches a long overdue effort to explore these wider issues. Readers are invited to submit papers to Charles MacKay, 5011 Worthington Drive, Bethesda, MD 20816, USA. E-mail: [email protected]. aMy notes
Similar books and articles
Making Risk-Benefit Assessments of Medical Research Protocols.Alex Rajczi - 2004 - Journal of Law, Medicine and Ethics 32 (2):338-348.
The Low Risk Research Ethics Application Process at CQUniversity Australia.Teresa Moore & Kristy Richardson - 2013 - Journal of Academic Ethics 11 (3):211-230.
Medical risk and the right to an informed consent in clinical care and clinical research.Dennis John Mazur - 1998 - Tampa, Fla.: American College of Physician Executives.
Retractions in the medical literature: how many patients are put at risk by flawed research?R. G. Steen - 2011 - Journal of Medical Ethics 37 (11):688-692.
Beyond Human Subjects: Risk, Ethics, and Clinical Development of Nanomedicines.Jonathan Kimmelman - 2012 - Journal of Law, Medicine and Ethics 40 (4):841-847.
Valuing risk: The ethical review of clinical trial safety.Jonathan Kimmelman - 2004 - Kennedy Institute of Ethics Journal 14 (4):369-393.
Philosophical reflections on medical ethics.Nafsika Athanassoulis (ed.) - 2005 - New York: Palgrave-Macmillan.
Clarifying confusions about coercion.Jennifer Susan Hawkins & Ezekiel J. Emanuel - 2005 - Hastings Center Report 35 (5):16-19.
Individual risk and community benefit in international research.Robert C. Hughes - 2012 - Journal of Medical Ethics 38 (10):626-629.
Concepts of Risk in Nanomedicine Research.Linda F. Hogle - 2012 - Journal of Law, Medicine and Ethics 40 (4):809-822.
A virtue ethical account of making decisions about risk.N. Athanassoulis & A. Ross - 2010 - Journal of Risk Research 13 (2):217.
The influence of risk and monetary payment on the research participation decision making process.J. P. Bentley - 2004 - Journal of Medical Ethics 30 (3):293-298.
Analytics
Added to PP
2010-08-24
Downloads
31 (#504,675)
6 months
4 (#800,606)
2010-08-24
Downloads
31 (#504,675)
6 months
4 (#800,606)
Historical graph of downloads
Citations of this work
Four Faces of Fair Subject Selection.Katherine Witte Saylor & Douglas MacKay - 2020 - American Journal of Bioethics 20 (2):5-19.
Recommendations for Nanomedicine Human Subjects Research Oversight: An Evolutionary Approach for an Emerging Field.Leili Fatehi, Susan M. Wolf, Jeffrey McCullough, Ralph Hall, Frances Lawrenz, Jeffrey P. Kahn, Cortney Jones, Stephen A. Campbell, Rebecca S. Dresser, Arthur G. Erdman, Christy L. Haynes, Robert A. Hoerr, Linda F. Hogle, Moira A. Keane, George Khushf, Nancy M. P. King, Efrosini Kokkoli, Gary Marchant, Andrew D. Maynard, Martin Philbert, Gurumurthy Ramachandran, Ronald A. Siegel & Samuel Wickline - 2012 - Journal of Law, Medicine and Ethics 40 (4):716-750.
The right to withdraw from controlled human infection studies: Justifications and avoidance.Holly Fernandez Lynch - 2020 - Bioethics 34 (8):833-848.
Nanomedicine First-in-Human Research: Challenges for Informed Consent.Nancy M. P. King - 2012 - Journal of Law, Medicine and Ethics 40 (4):823-830.
Beyond Human Subjects: Risk, Ethics, and Clinical Development of Nanomedicines.Jonathan Kimmelman - 2012 - Journal of Law, Medicine and Ethics 40 (4):841-847.
PhilPapers logo by Andrea Andrews and Meghan Driscoll.
This site uses cookies and Google Analytics (see our terms & conditions for details regarding the privacy implications). Use of this site is subject to terms & conditions.
All rights reserved by The PhilPapers Foundation
Server: philpapers-web-7c76586df8-l2pxr uwo